ClearBridge Investments’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-203,541
Closed -$5.22M 717
2025
Q2
$5.22M Sell
203,541
-31,970
-14% -$936K ﹤0.01% 564
2025
Q1
$8.62M Sell
235,511
-64,094
-21% -$2.2M 0.01% 515
2024
Q4
$9.19M Sell
299,605
-3,521
-1% -$117K 0.01% 542
2024
Q3
$11.4M Sell
303,126
-8,575
-3% -$331K 0.01% 520
2024
Q2
$12.3M Sell
311,701
-6,320
-2% -$205K 0.01% 514
2024
Q1
$10.7M Buy
318,021
+6,844
+2% +$230K 0.01% 539
2023
Q4
$10.4M Buy
311,177
+1,979
+0.6% +$63.8K 0.01% 543
2023
Q3
$9.7M Sell
309,198
-7,896
-2% -$248K 0.01% 517
2023
Q2
$10M Buy
317,094
+3,150
+1% +$102K 0.01% 517
2023
Q1
$10.4M Buy
313,944
+6,085
+2% +$199K 0.01% 508
2022
Q4
$9.9M Sell
307,859
-3,204
-1% -$109K 0.01% 519
2022
Q3
$11.1M Buy
311,063
+61,478
+25% +$2.55M 0.01% 505
2022
Q2
$10.3M Buy
249,585
+13,527
+6% +$657K 0.01% 527
2022
Q1
$13.7M Buy
236,058
+2,204
+0.9% +$121K 0.01% 533
2021
Q4
$13.7M Sell
233,854
-18,629
-7% -$1.13M 0.01% 545
2021
Q3
$15.3M Sell
252,483
-48,209
-16% -$2.83M 0.01% 536
2021
Q2
$18M Sell
300,692
-3,758
-1% -$188K 0.01% 529
2021
Q1
$14.4M Buy
+304,450
New +$12.5M 0.01% 535

Other funds holding ATEX

ClearBridge Investments's ATEX Position: Q3 2025 in Review

ClearBridge Investments sold out of Anterix (ATEX) in Q3 2025, closing a stake of 203,541 shares — an estimated $5.22M sold.

ClearBridge Investments first reported a position in ATEX in Q1 2021 and held it in 18 quarters. The position peaked at $18M in Q2 2021. 111 funds tracked by Wall St. Rank hold ATEX as of Q3 2025.

  • ClearBridge Investments reported no remaining Anterix position as of Q3 2025 after selling out during the quarter.
  • ClearBridge Investments sold 203,541 Anterix shares in Q3 2025, an estimated $5.22M.
  • ClearBridge Investments first reported a position in Anterix in Q1 2021 and held it in 18 quarters.
  • ClearBridge Investments's Anterix position peaked at $18M in Q2 2021.
  • 111 funds tracked by Wall St. Rank held Anterix as of Q3 2025.

Based on ClearBridge Investments's 13F filing for Q3 2025, filed 13 Nov 2025.